Word

EXPLORE44-OLE

Status

Pending

Status Code

681

Status Date

Thursday, May 2, 2024

Serial Number

98084163

Mark Type

3

Filing Date

Thursday, July 13, 2023

Published for Opposition

Tuesday, June 4, 2024

Trademark Owner History

Avidity Biosciences, Inc.

Classifications

5 Antibodies for medical purposes comprising oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes

42 Medical and scientific research, namely, conducting clinical trials for others for oligonucleotide-based therapeutics in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes

The mark consists of the EXPLORE text to the left of a 44 text inside of a partially full circle a top of a boat with 2 parallel wavy lines with one longer than the other at the bottom of the boat and a hyphen OLE text to the right.
EXPLORE FOUR FOUR OLE; EXPLORE FORTY FOUR OLE
Color is not claimed as a feature of the mark.

Trademark Events

Jul 17, 2023

New Application Entered

Aug 13, 2023

New Application Office Supplied Data Entered

Aug 15, 2023

Notice Of Design Search Code E-Mailed

Feb 23, 2024

Teas Voluntary Amendment Received

Feb 23, 2024

Teas Amendment Entered Before Attorney Assigned

Mar 21, 2024

Assigned To Examiner

Mar 26, 2024

Non-Final Action Written

Mar 26, 2024

Non-Final Action E-Mailed

Mar 26, 2024

Notification Of Non-Final Action E-Mailed

Apr 25, 2024

Correspondence Received In Law Office

Apr 25, 2024

Teas/Email Correspondence Entered

Apr 25, 2024

Teas Response To Office Action Received

May 1, 2024

Approved For Pub - Principal Register